Alghitran Abdulrahman, AlOsaimi Hind M, Albuluwi Ahmad, Almalki Emad Omar, Aldowayan Abdullah Zohair, Alharthi Rakan, Qattan Jawad Mohammed, Alghamdi Fahd, AlHalabi Mohammed, Almalki Nawaf Ayed, Alharthi Abdulaziz, Alshammari Asma, Kanan Muhammad
A General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, Saudi Arabia.
Department of Pharmacy Services Administration, King Fahad Medical City, Riyadh Second Health Cluster, Riyadh, Saudi Arabia.
Integr Pharm Res Pract. 2025 Mar 17;14:31-43. doi: 10.2147/IPRP.S500689. eCollection 2025.
Artificial Intelligence (AI), especially ChatGPT, is rapidly assimilating into healthcare, providing significant advantages in pharmacy practice, such as improved clinical decision-making, patient counselling, and drug information management. The adoption of AI tools is heavily contingent upon pharmacy practitioners' knowledge, attitudes, and practices (KAP). This study sought to evaluate the knowledge and practices of pharmacists in Saudi Arabia concerning the utilization of ChatGPT in their daily activities.
A cross-sectional study was performed from May 2023 to July 2024 including pharmacists in Riyadh, Saudi Arabia. An online pre-validated KAP questionnaire was disseminated, collecting data on demographics, knowledge, attitudes, and practices about ChatGPT. Descriptive statistics and regression analyses were conducted using SPSS.
Of 1022 respondents, 78.7% were familiar with AI in pharmacy, while 90.1% correctly identified ChatGPT as an advanced AI chatbot. Positive attitudes towards ChatGPT were reported by 64.1% of pharmacists, although only 24.3% used AI tools regularly. Significant predictors of positive attitudes and practices included academic/research roles (β=0.7, p=0.005) and 6-10 years of experience (β=0.9, p=0.05). Ethical concerns were raised by 64% of respondents, and 92% reported a lack of formal training.
While the majority of pharmacists held positive attitudes toward ChatGPT, practical implementation remains limited due to ethical concerns and inadequate training. Addressing these barriers is essential for successful AI integration in pharmacy, supporting Saudi Arabia's Vision 2030 initiative.
人工智能（AI），尤其是ChatGPT，正在迅速融入医疗保健领域，在药学实践中具有显著优势，如改善临床决策、患者咨询和药物信息管理。人工智能工具的采用在很大程度上取决于药剂师的知识、态度和实践（KAP）。本研究旨在评估沙特阿拉伯药剂师在日常活动中使用ChatGPT的知识和实践情况。
2023年5月至2024年7月进行了一项横断面研究，纳入了沙特阿拉伯利雅得的药剂师。发放了一份经过预验证的在线KAP问卷，收集有关人口统计学、关于ChatGPT的知识、态度和实践的数据。使用SPSS进行描述性统计和回归分析。
在1022名受访者中，78.7%熟悉药学领域的人工智能，而90.1%正确将ChatGPT识别为先进的人工智能聊天机器人。64.1%的药剂师对ChatGPT持积极态度，尽管只有24.3%的人经常使用人工智能工具。积极态度和实践的显著预测因素包括学术/研究角色（β=0.7，p=0.005）和6至10年的工作经验（β=0.9，p=0.05）。64%的受访者提出了伦理问题，92%的人表示缺乏正规培训。
虽然大多数药剂师对ChatGPT持积极态度，但由于伦理问题和培训不足，实际应用仍然有限。解决这些障碍对于人工智能在药学领域的成功整合至关重要，有助于支持沙特阿拉伯的2030年愿景倡议。
